88
Views
11
CrossRef citations to date
0
Altmetric
Original Research

The effect of intravenous hydration strategy on plasma methotrexate clearance during intravenous high-dose methotrexate administration in pediatric oncology patients

, , &
Pages 4471-4478 | Published online: 10 Oct 2018

References

  • HerfarthHHMethotrexate for Inflammatory Bowel Diseases - New DevelopmentsDig Dis2016341–214014626981630
  • WeinblattMEMethotrexate in rheumatoid arthritis: a quarter century of developmentTrans Am Clin Climatol Assoc2013124162523874006
  • HowardSCMccormickJPuiCHBuddingtonRKHarveyRDPreventing and Managing Toxicities of High-Dose MethotrexateOncologist201621121471148227496039
  • StollerRGHandeKRJacobsSARosenbergSAChabnerBAUse of plasma pharmacokinetics to predict and prevent methotrexate toxicityN Engl J Med197729712630634302412
  • MitchellMSWawroNWDecontiRCKaplanSRPapacRBertinoJREffectiveness of high-dose infusions of methotrexate followed by leucovorin in carcinoma of the head and neckCancer Res1968286108810944298056
  • AbreyLEDeangelisLMYahalomJLong-term survival in primary CNS lymphomaJ Clin Oncol19981638598639508166
  • MoePJHolenAHigh-dose methotrexate in childhood allPediatr Hematol Oncol200017861562211127393
  • CooperSLBrownPATreatment of pediatric acute lymphoblastic leukemiaPediatr Clin North Am2015621617325435112
  • PuiCHRellingMVEvansWEIs mega dose of methotrexate beneficial to patients with acute lymphoblastic leukemia?Leuk Lymphoma200647122431243217169783
  • PDQ® Pediatric Treatment Editorial Board Childhood Non-Hodgkin Lymphoma Treatment (PDQ(R)): Health Professional Version PDQ Cancer Information SummariesBethesda, MDNational Cancer Institute2002
  • WoessmannWSeidemannKMannGThe impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95Blood2005105394895815486066
  • ChoeyprasertWPakakasamaSSirachainanNComparative outcome of Thai pediatric osteosarcoma treated with two protocols: the role of high-dose methotrexate (HDMTX) in a single institute experienceAsian Pac J Cancer Prev201415229823982925520112
  • IsakoffMSBielackSSMeltzerPGorlickROsteosarcoma: Current Treatment and a Collaborative Pathway to SuccessJ Clin Oncol201533273029303526304877
  • Patiño-GarcíaAZalacaínMMarrodánLSan-JuliánMSierrasesúmagaLMethotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expressionJ Pediatr2009154568869319159907
  • HolmboeLAndersenAMMørkridLSlørdalLHallKSHigh dose methotrexate chemotherapy: pharmacokinetics, folate and toxicity in osteosarcoma patientsBr J Clin Pharmacol201273110611421707700
  • FleisherMAntifolate analogs: mechanism of action, analytical methodology, and clinical efficacyTher Drug Monit19931565215268122287
  • GoodsellDSThe molecular perspective: methotrexateStem Cells199917531431510527466
  • RajagopalanPTZhangZMccourtLDwyerMBenkovicSJHammesGGInteraction of dihydrofolate reductase with methotrexate: ensemble and single-molecule kineticsProc Natl Acad Sci U S A20029921134811348612359872
  • Longo-SorbelloGSBertinoJRCurrent understanding of methotrexate pharmacology and efficacy in acute leukemias. Use of newer antifolates in clinical trialsHaematologica200186212112711224479
  • KhanZATripathiRMishraBMethotrexate: a detailed review on drug delivery and clinical aspectsExpert Opin Drug Deliv20129215116922251428
  • BhojwaniDSabinNDPeiDMethotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemiaJ Clin Oncol201432994995924550419
  • FerrariSOrlandiMAvellaMEffects of hydration on plasma concentrations of methotrexate in patients with osteosarcoma treated with high doses of methotrexateMinerva Med19928352892931589134
  • KarremannMSauerbierJMeierCThe impact of prehydration on the clearance and toxicity of high-dose methotrexate for pediatric patientsLeuk Lymphoma201455122874287824576168
  • MikkelsenTSMamoudouADTuckuvieneRWehnerPSSchroederHExtended duration of prehydration does not prevent nephrotoxicity or delayed drug elimination in high-dose methotrexate infusions: a prospectively randomized cross-over studyPediatr Blood Cancer201461229730124039194
  • KinoshitaAKurosawaYKondohKEffects of sodium in hydration solution on plasma methotrexate concentrations following high-dose methotrexate in children with acute lymphoblastic leukemiaCancer Chemother Pharmacol200351325626012655445
  • TreonSPChabnerBAConcepts in use of high-dose methotrexate therapyClin Chem1996428 Pt 2132213298697606